Association of the risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 vaccines

Trial Identifier:	D8111R00010
Sponsor:	AstraZeneca
NCTID::	NCT05252442
Start Date:	March 2022
Primary Completion Date:	July 2023
Study Completion Date:	July 2023
Condition:	COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Oxford, United Kingdom, OX12JD

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.